Research Article

Catecholaminergic Gene Variants: Contribution in ADHD and Associated Comorbid Attributes in the Eastern Indian Probands

Table 4

Case-control analysis of allelic frequencies in ADHD probands with various co-morbidities.

SiteADHD comorbidity
( )
ADHD + CD
( )
 ADHD + LD
( )
 ADHD + ODD
  ( )
 ADHD + MD
 ( )
  (P)OR
(95% CI)
  (P)OR
(95% CI)
  (P)OR
(95% CI)
  (P)OR
(95% CI)
  (P)OR
(95% CI)

rs38370914.67
(0.03)
1.97
(1.06–3.65)
0.00
(0.77)
1.09
(0.61–1.94)
0.20
(0.66)
1.14
(0.64–2.04)
0.00
(0.88)
0.96
(0.54–1.70)
3.44
(0.06)
0.59
(0.33–1.03)
rs37352730.00
(1.00)
1
(0.53–1.90)
6.49
(0.01)
2.17
(1.19–3.97)
0.41
(0.52)
1.23
(0.66–2.29)
0.00
(0.87)
0.95
(0.50–1.81)
3.02
(0.08)
1.71
(0.93–3.16)
rs17997320.02
(0.89)
1.1
(0.47–2.54)
0.59
(0.44)
1.51
(0.61–3.71)
4.64
(0.03)
2.84
(0.97–8.29)
0.21
(0.64)
0.85
(0.38–1.89)
1.96
(0.16)
2.84
(0.97–8.29)
rs46469840.12
(0.73)
1.11
(0.59–2.09)
4.39
(0.04)
1.91
(1.05–3.51)
1.67
(0.20)
1.47
(0.79–2.73)
1.18
(0.28)
1.41
(0.76–2.62)
0.003
(0.95)
1
(0.53–1.90)
rs46469830.41
(0.52)
1.42
(0.55–3.69)
4.70
(0.03)
2.52
(1.04–6.11)
3.16
(0.08)
2.03
(0.82–5.03)
4.75
(0.03)
2.52
(1.04–6.11)
4.29
(0.04)
2.88
(1.20–6.88)
rs1655992.03
(0.15)
1.46
(0.83–2.60)
0.55
(0.46)
1.24
(0.70–2.20)
4.21
(0.04)
1.72
(0.97–3.04)
0.08
(0.78)
0.91
(0.50–1.64)
0.01
(0.91)
0.95
(0.53–1.72)
rs7406030.41
(0.52)
1.17
(0.67–2.04)
0.09
(0.76)
1.12
(0.65–1.96)
0.03
(0.88)
1.08
(0.62–1.88)
3.89
(0.04)
1.76
(1.0–3.09)
7.14  
(0.007)
2.51
(1.41–4.47)

NB: significant P values are presented in bold.